- Biogen and Stoke Therapeutics Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome Biogen
- Beyond Seizures: Zorevunersen’s Impact on Cognition and Function NeurologyLive
- Biogen & Stoke: Zorevunersen Shows 95% Clinical Improvement at 3 Years | BIIB Stock News Stock Titan
- Overviewing Early-Stage Efficacy, Safety Data of Zorevunersen NeurologyLive
- Zorevunersen and the Next Chapter of Dravet Syndrome Care NeurologyLive
Blog
-
Biogen and Stoke Therapeutics Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome – Biogen
-
Rüfüs Du Sol, Chase & Status Win at 2025 DJ Awards
Rüfüs du Sol and Chase & Status were among the winners at The DJ Awards 2025, which were held at ROTO Club in Ibiza Town, in Ibiza, Spain on Thursday (Oct. 9). This year’s ceremony marked the 24th edition of the DJ Awards, an independent…
Continue Reading
-
Massive impact crater may rewrite the Moon’s origin story
When NASA’s Artemis astronauts touch down near the Moon’s south pole, they may step into a natural archive of the Moon’s deepest secrets.
A new study, led by Jeffrey Andrews-Hanna at the University of Arizona, argues that this region lies on…
Continue Reading
-
Johnson & Johnson to Participate in the UBS Global Healthcare Conference
New Brunswick, N.J., October 9th, 2025 – Johnson & Johnson (NYSE: JNJ) will present at the UBS Global Healthcare Conference on Tuesday, November 11th, 2025. Management will participate in a Fireside Chat at 11:00 a.m. Eastern Time.
A live audio webcast of the presentation will be accessible through Johnson & Johnson’s Investor Relations website at
www.investor.jnj.com. An archived edition of the session will be available later that day.The audio webcast replay will be available approximately 48 hours after the webcast.
Continue Reading
-
HIMSA Launches Noah 4.117 with Major Security Upgrades
Summary:
HIMSA has released Noah 4.117, a modernized version of its Noah System platform featuring major security upgrades and the end of support for legacy NOAH 3 modules.Key Takeaways:
- Noah 4.117 introduces extensive security…
Continue Reading
-
Levi Strauss (LEVI) Q3 2025 earnings
Levi Strauss‘s profits are growing more than Wall Street expected despite higher costs from tariffs, thanks to targeted price increases and a shift away from wholesalers, the company said Thursday as it reported fiscal third quarter results.
During the quarter, Levi’s gross margin grew 1.1 percentage points to 61.7%, up from 60.6% in the year-ago period and better than the 60.7% analysts had expected, according to StreetAccount.
In an interview with CNBC, CEO Michelle Gass said the company has started to raise the price of some of its jeans and clothes and will hike more prices in the U.S. and other markets next year.
“As we’ve been taking these targeted actions, we’ve not seen an impact to demand. We’ll of course, stay very, very close to that but … we’re taking a surgical, thoughtful approach on any pricing,” said Gass. “We know that we’re a brand that is known for great quality and value. We don’t take that for granted. We know we have to earn that every day.”
Finance chief Harmit Singh added demand is “really strong” and most of the company’s revenue growth is not coming from price increases.
Price hikes are helping Levi’s margins, but the company is also discounting less and selling more through its own website and stores instead of wholesalers, which comes at a higher margin.
The denim maker said its strong results led it to raise its full-year outlook, but added it’s still taking a “prudent” and “conservative” look at the rest of the year as it navigates ongoing macroeconomic volatility, Singh said.
Here’s how Levi’s performed during the quarter compared with what Wall Street was anticipating, based on a survey of analysts by LSEG:
- Earnings per share: 34 cents adjusted vs. 31 cents expected
- Revenue: $1.54 billion vs. $1.50 billion expected
Though Levi’s posted better-than-expected results, shares dropped more than 6% in extended trading. Its stock had climbed about 42% this year through Thursday’s close.
The company’s reported net income for the three-month period that ended Aug. 31 was $218 million, or 55 cents per share, compared with $20.7 million, or 5 cents per share, a year earlier. Excluding one-time items related to impairment and restructuring charges, among other expenses, Levi posted adjusted earnings of 34 cents per share.
Sales rose to $1.54 billion, up 7% from $1.44 billion a year earlier.
Levi’s is now expecting its full year sales to rise 3%, up from its prior guidance of between 1% and 2% growth, far exceeding expectations of a 2.9% decline, according to LSEG.
It’s expecting its full year adjusted earnings per share to be between $1.27 and $1.32, up from a prior range of between $1.25 and $1.30. At the high end, the outlook is in line with Wall Street estimates of $1.31 per share, according to LSEG.
The jeans company said it’s expecting its operating margin to be between 11.4% and 11.6%, which is also in line with expectations of 11.6%, according to StreetAccount. It’s now expecting its gross margin to rise by 1 percentage point, which is the outlook Levi’s delivered earlier this year before it factored tariffs into its forecast. At the time, its guidance didn’t reflect any tariff impact. The following quarter, it cut its gross margin guidance by 0.2 percentage points because of the new duties.
Now, Levi’s is returning to that original outlook, as long as U.S. tariffs on imports from China remain at 30% and rest-of-world duties stay at 20% for the remainder of the year.
Under the direction of Gass, Levi’s has been working to grow its direct sales, expand beyond jeans and win over more female shoppers – strategies that helped the business grow both its top and bottom lines.
During the quarter, direct-to-consumer revenue, or sales from Levi’s website and stores, grew 11%, driven by strength in the U.S. market, while women’s was up 9%. Levi’s is benefiting from strong momentum in the denim category, but the company is growing its assortment outside of just jeans, which gives it a hedge if fashion trends change.
Other types of clothes beyond denim bottoms, including tops, now make up nearly 40% of the business. The company’s efforts to sell more tops is also resonating with consumers, as that category was up 9% during the quarter.
Continue Reading
-
Apple Watch HTN Alert Moves BP Clues From Clinic to Wrist – Medscape
- Apple Watch HTN Alert Moves BP Clues From Clinic to Wrist Medscape
- watchOS 26 brings two powerful Health features for Apple Watch 9to5Mac
- Hypertension notifications available today on Apple Watch Apple
- Apple rolls out new hypertension alert…
Continue Reading
-
2026 World Cup Qualifiers : Algeria beats Somalia 3-0 to qualify – Dailysports
- 2026 World Cup Qualifiers : Algeria beats Somalia 3-0 to qualify Dailysports
- Somalia 0-3 Algeria: Riyad Mahrez leads Algeria back to World Cup finals BBC
- Mo Salah double helps Egypt achieve FIFA World Cup qualification Olympics.com
- Tebboune…
Continue Reading
-
9 Best Micellar Waters to Gently Remove All Traces of Makeup
The best micellar water is an underrated superstar when it comes to removing all the grime that builds up just from being out and about. “The very reason you’re cleansing is to prep your skin to receive treatment: whether it’s an acid,
Continue Reading